Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters











Database
Language
Publication year range
1.
Nat Prod Res ; 35(22): 4409-4416, 2021 Nov.
Article in English | MEDLINE | ID: mdl-32272852

ABSTRACT

Three new ester glycosides, named as Caesateroside A (1), Caesateroside B (2) and Caesateroside C (3) were obtained from the seeds of Caesalpinia sappan. The new structures of compounds 1-3 were elucidated by analyzing their 1 D NMR, 2 D NMR and HR-ESI-MS spectra. Compounds 1-3 showed weak-moderate cytotoxicity against Hela and HepG-2 human cancer cell lines.


Subject(s)
Caesalpinia , Diterpenes , Esters , Glycosides/pharmacology , Humans , Molecular Structure , Seeds
2.
Cell Death Dis ; 11(9): 781, 2020 09 19.
Article in English | MEDLINE | ID: mdl-32951003

ABSTRACT

Drug-induced liver injury is the major cause of acute liver failure. However, the underlying mechanisms seem to be multifaceted and remain poorly understood, resulting in few effective therapies. Here, we report a novel mechanism that contributes to acetaminophen-induced hepatotoxicity through the induction of ferroptosis, a distinctive form of programmed cell death. We subsequently identified therapies protective against acetaminophen-induced liver damage and found that (+)-clausenamide ((+)-CLA), an active alkaloid isolated from the leaves of Clausena lansium (Lour.) Skeels, inhibited acetaminophen-induced hepatocyte ferroptosis both in vivo and in vitro. Consistently, (+)-CLA significantly alleviated acetaminophen-induced or erastin-induced hepatic pathological damages, hepatic dysfunctions and excessive production of lipid peroxidation both in cultured hepatic cell lines and mouse liver. Furthermore, treatment with (+)-CLA reduced the mRNA level of prostaglandin endoperoxide synthase 2 while it increased the protein level of glutathione peroxidase 4 in hepatocytes and mouse liver, confirming that the inhibition of ferroptosis contributes to the protective effect of (+)-CLA on drug-induced liver damage. We further revealed that (+)-CLA specifically reacted with the Cys-151 residue of Keap1, which blocked Nrf2 ubiquitylation and resulted in an increased Nrf2 stability, thereby leading to the activation of the Keap1-Nrf2 pathway to prevent drug-induced hepatocyte ferroptosis. Our studies illustrate the innovative mechanisms of acetaminophen-induced liver damage and present a novel intervention strategy to treat drug overdose by using (+)-CLA.


Subject(s)
Chemical and Drug Induced Liver Injury/drug therapy , Ferroptosis/drug effects , Hepatocytes/drug effects , Lactams/pharmacology , Lignans/pharmacology , Liver/injuries , Animals , Chemical and Drug Induced Liver Injury/pathology , Hepatocytes/metabolism , Liver/metabolism , Liver Failure, Acute/metabolism , Male , Mice, Inbred C57BL , Oxidative Stress/drug effects , Protective Agents/pharmacology , Reactive Oxygen Species/metabolism
3.
Biosci Biotechnol Biochem ; 84(8): 1621-1628, 2020 Aug.
Article in English | MEDLINE | ID: mdl-32419644

ABSTRACT

A critical pathogenic factor in the development of lethal liver failure is cell death induced by the accumulation of lipid reactive oxygen species. In this study, we discovered and illuminated a new mechanism that led to alcoholic liver disease via ferroptosis, an iron-dependent regulated cell death. Study in vitro showed that both necroptosis inhibitor and ferroptosis inhibitors performed significantly protective effect on alcohol-induced cell death, while apoptosis inhibitor and autophagy inhibitor had no such effect. Our data also indicated that alcohol caused the accumulation of lipid peroxides and the mRNA expression of prostaglandin-endoperoxide synthase 2, reduced the protein expression of the specific light-chain subunit of the cystine/glutamate antiporter and glutathione peroxidase 4. Importantly, ferrostatin-1 significantly ameliorated liver injury that was induced by overdosed alcohol both in vitro and in vivo. These findings highlight that targeting ferroptosis serves as a hepatoprotective strategy for alcoholic liver disease treatment.


Subject(s)
Cyclohexylamines/pharmacology , Ethanol/toxicity , Ferroptosis/drug effects , Iron/metabolism , Liver Diseases, Alcoholic/genetics , Liver/drug effects , Phenylenediamines/pharmacology , Adenine/analogs & derivatives , Adenine/pharmacology , Amino Acid Chloromethyl Ketones/pharmacology , Amino Acid Transport System y+/genetics , Amino Acid Transport System y+/metabolism , Animals , Autophagy/drug effects , Autophagy/genetics , Cell Line , Cyclooxygenase 2/genetics , Cyclooxygenase 2/metabolism , Disease Models, Animal , Female , Ferroptosis/genetics , Gene Expression Regulation , Hepatocytes/drug effects , Hepatocytes/metabolism , Hepatocytes/pathology , Humans , Imidazoles/pharmacology , Indoles/pharmacology , Lipid Peroxidation/drug effects , Liver/metabolism , Liver/pathology , Liver Diseases, Alcoholic/etiology , Liver Diseases, Alcoholic/pathology , Liver Diseases, Alcoholic/prevention & control , Mice , Mice, Inbred C57BL , Phospholipid Hydroperoxide Glutathione Peroxidase/genetics , Phospholipid Hydroperoxide Glutathione Peroxidase/metabolism , Signal Transduction , Vitamin E/pharmacology
SELECTION OF CITATIONS
SEARCH DETAIL